Brief: Imunon Research And Development Day: Opportunity To Hear Clinical Trial Investigators Discuss Significant Potential Of IMNN-001 To Redefine Ovarian Cancer Treatment
07/11/2025 13:12
Nov 7 (Reuters) - Imunon Inc IMNN.O: IMUNON RESEARCH AND DEVELOPMENT DAY: OPPORTUNITY TO HEAR CLINICAL TRIAL INVESTIGATORS DISCUSS SIGNIFICANT POTENTIAL OF IMNN-001 TO REDEFINE OVARIAN CANCER TREATMENT Source text: ID:nGNX7yPDdc Further company coverage: IMNN.O ((Reuters.Briefs@thomsonreuters.com;))